Infiltrazini Polarizzate Di Orgoteina Nel Morbo Di La Peyronie

Bartsch G. , Menander-Huber K. B. , Marberger H. : Orgotein, a new drug for the treatment of Peyronie's disease. Eur. J. Rheumatol. Inflamm., 4; 250–259 (1981).

Bassi E. , Felici E. : Induratio penis plastica. Nostra esperienza nella terapia con procarbazina. Urologia, 48; 254–258 (1981).

Bernacchi F. : Considerazioni sull'eziopatogenesi della induratio penis. Urologia, 37; 70 (1970).

Bystrom J. : I.P.P.: the results of the various formes of treatment. Scand. J. Urol. Nephrol., 6; 105 (1973).

Bystrom J. : I.P.P.: Clinical features and etiology. Scand. J. Urol. Nephrol., 13; 10 (1976).

Chiltol C. P. , Castle W. M. , Westwood C. A. , Pryor J. P. : Factors associated in the aetiology of Peyronie's disease. Brit. J. Urol., 54; 749–750 (1982).

Chesney G. J. : Peyronies's disease. Brit. J. Urol., 47; 209 (1975).

Devine C. J. , Horton C. E. : Surgical treatment of I.P.P. with a dermal graft. J. Urol., 111; 44 (1974).

Gustafson H. , Johannson B. , Edsmyr F. : Peyronie's disease: experience of local treatment with orgotein. Eur. Urol., 7; 346 (1981).

Hinman F. Jr. : Etiologic factors in Peyronie's disease. Urol. Intern., 35; 407–413 (1980).

Kierkegaard E. , Nielsen B. : Treatment of Peyronie's disease with k-para-aminobenzoate and Vitamin E. Ugeskr. Laeg., 141; 2052–2053 (1979).

La Vecchia G. , Fabrizi G. , Garcovich A. : Gli ultrasuoni nel trattamento dell'Induratio Penis Plastica. G. Ital. Dermatol., Minerva Dermatol., 114; 547–552 (1979).

Mantovani F. , Meroni P. L. , Austoni E. , Bellorofonte C. , Patelli E. : La malattia di La Peyronie come collagenopatia autoimmune. Urologia, 50; 20–22 (1983).

Marberger H. , Huber W. , Bartsch G. , Schulte T. , Swoboda P. : Orgotein: a new inflammatory metallprotein. Drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Intern. Urol. Nephrol., 6; 61 (1974).

Miller H. C. , Ardizzone J. : Peyronie disease treated with ultrasound and hydrocortisone. Urology, 21; 584–585 (1983).

Mester E. : Experimental and clinical observations with laser. Pan-Minerva med., 13; 538–543 (1971).

Morgan R. J. , Pryor J. P. : Procarbazine (Natulan) in the treatment of Peyronie's disease. Brit. J. Urol., 50; 111–113 (1978).

Pagano S. A. : Revisione della letteratura alla luce di un nuovo trattamento per l'I.P.P.: thiomucase. Riabilitaz., 9 (1976).

Pisani E. , Mantovani F. , Patelli E. , Austoni E. : L'orgoteina per infiltrazione ed jonoforesi nel trattamento dell'I.P.P. Proc. 56th Congr. S.I.U., p. 70–73 (1983).

Poutasse E. F. : Peyronie's disease. J. Urol., 107; 419 (1972).

Pryor J. P. , Castle W. M. : Peyronie's disease associated with chronic degenerative arterial disease and not with beta-adrenoreceptor blocking agents. Lancet, 2; 917 (1982).

Pugh R. C. S. : The pathology of fibrotic lesions. Proc. Roy. Soc. Med., 53; 685 (1960).

Scarpa R. M. , Campisi G. , Corona G. , Manca P. , Usai E. : Il trattamento ionoforetico con Orgoteina della malattia di La Peyronie e suo controllo clinico mediante ecografia peniena. Nota preliminare. Urologia, 50; 1049–1056 (1983).

Schubert G. E. : Induratio Penis Plastica, pathomorphologische Gesichtspunkte. Induratio-Penis-Plastica Symposium, Bonn 1984.

Toksu E. : I.P.P.: A method of treatment. J. Urol., 105; 52 3(1970).

Williams J. L. : The natural history of Peyronie's disease. J. Urol., 103; 75 (1970).